Blog

Clues to Why a Breakthrough Pancreatic Cancer Drug Eventually Stops Working

NCC recently completed funding a pancreatic research study at Columbia University. These funds are vital to both the scientific advancement of the project as well as establishing early independent investigators…
Read more

F.D.A. Approves Drug Poised to Transform Care for Pancreatic Cancer

NCC supports pancreatic cancer research at Columbia University with a $122,000 postdoctoral grant!

Most Americans drink at least one soda a day. It’s associated with this type of cancer

Cracking open that can of soda each day may be raising your risk of certain cancers, according to new research.

3 minutes of this activity may cut the risk of 13 cancers, study finds

The research offers a new look at how simply sitting less and moving more may affect cancer risk.

Dana-Farber Cancer Institute’s Impact Magazine Recognizes NCC

Dana-Farber Cancer Institute’s Impact Magazine has recognized NCC for our postdoctoral research fellowships awarded to four of their researchers! National Cancer Center – Impact Magazine

National Cancer Center Is Pleased to Name Allison Betof-Warner, M.D., Ph.D., and Rizwan Romee, M.D., to Scientific Advisory Board

NEW YORK–(BUSINESS WIRE)–National Cancer Center is pleased to announce the appointment of Allison Betof-Warner, M.D., Ph.D. and Rizwan Romee, M.D., to its Scientific Advisory Board. NCC adds leading cancer researchers…
Read more

Early Research Suggests a Path to Predict and Prevent Lung Cancer

Early research suggests a path to predict and prevent lung cancer. NCC is currently funding lung cancer research at Dana-Farber Cancer Institute for a project entitled, Deciphering spatial and genetic…
Read more

Promising New Pancreatic Cancer Treatment Featured in The New York Times

NCC continues to fund the scientists at Massachusetts Institute of Technology, Johns Hopkins and Harvard University. Please support this important and this vital cancer research into pancreatic, lung and colon…
Read more

The Urgent Need for Better Pancreatic Cancer Treatments

The need for effective pancreatic cancer treatment is acute as it is the deadliest in terms of survivability. It’s the third-leading cause of U.S. cancer deaths, with five-year survival of…
Read more

NCC Funds $122,000 in Pancreatic Cancer Research at Columbia University

NCC is proud to support funding of pancreatic cancer research at Columbia University in the amount of $122,000. Please continue to donate to NCC.